These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 8111066

  • 21. von Willebrand factor competes with fibrin for occupancy of GPIIb:IIIa on thrombin-stimulated platelets.
    Hantgan RR, Nichols WL, Ruggeri ZM.
    Blood; 1990 Feb 15; 75(4):889-94. PubMed ID: 2302458
    [Abstract] [Full Text] [Related]

  • 22. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 23. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J, Aleem AM, Selman SH, Skrzypczak-Jankun E, Lysiak-Szydlowska W, Grafos N, Fryer HJ, Greenfield RS.
    Int J Mol Med; 2007 Nov 02; 20(5):683-7. PubMed ID: 17912461
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
    Stringer HA, van Swieten P, Heijnen HF, Sixma JJ, Pannekoek H.
    Arterioscler Thromb; 1994 Sep 02; 14(9):1452-8. PubMed ID: 8068607
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP, Gurewich V, Johnstone M, Pannell R.
    Thromb Haemost; 1994 Mar 02; 71(3):347-52. PubMed ID: 8029800
    [Abstract] [Full Text] [Related]

  • 27. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction.
    Katagiri Y, Hiroyama T, Akamatsu N, Suzuki H, Yamazaki H, Tanoue K.
    J Biol Chem; 1995 Jan 27; 270(4):1785-90. PubMed ID: 7530248
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma.
    Serizawa K, Urano T, Kozima Y, Takada Y, Takada A.
    Thromb Res; 1993 Aug 15; 71(4):289-300. PubMed ID: 8236158
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.
    Katori N, Tanaka KA, Szlam F, Levy JH.
    Anesth Analg; 2005 Jun 15; 100(6):1781-1785. PubMed ID: 15920213
    [Abstract] [Full Text] [Related]

  • 35. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance.
    Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H.
    Blood; 1991 Jul 15; 78(2):401-9. PubMed ID: 1712649
    [Abstract] [Full Text] [Related]

  • 36. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood.
    van Giezen JJ, Nerme V, Abrahamsson T.
    Blood Coagul Fibrinolysis; 1998 Jan 15; 9(1):11-8. PubMed ID: 9607114
    [Abstract] [Full Text] [Related]

  • 37. Imaging analyses of coagulation-dependent initiation of fibrinolysis on activated platelets and its modification by thrombin-activatable fibrinolysis inhibitor.
    Brzoska T, Suzuki Y, Sano H, Suzuki S, Tomczyk M, Tanaka H, Urano T.
    Thromb Haemost; 2017 Apr 03; 117(4):682-690. PubMed ID: 28150854
    [Abstract] [Full Text] [Related]

  • 38. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.
    Podor TJ, Peterson CB, Lawrence DA, Stefansson S, Shaughnessy SG, Foulon DM, Butcher M, Weitz JI.
    J Biol Chem; 2000 Jun 30; 275(26):19788-94. PubMed ID: 10764803
    [Abstract] [Full Text] [Related]

  • 39. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M, Lijnen HR, Keber D, Collen D.
    Thromb Haemost; 1989 Dec 29; 62(4):1083-7. PubMed ID: 2515603
    [Abstract] [Full Text] [Related]

  • 40. Platelets interact with fibrin only after activation.
    Hantgan RR, Taylor RG, Lewis JC.
    Blood; 1985 Jun 29; 65(6):1299-311. PubMed ID: 3888311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.